샘플 요청 목록

 카트 문의
시장보고서
상품코드
1886018

세계의 헤르페스 마커 검사 시장

Herpes Marker Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 159 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 헤르페스 마커 검사 시장은 2030년까지 6억 5,240만 달러에 달할 전망

헤르페스 마커 검사 세계 시장은 2024년에 4억 9,000만 달러로 추정되며, 2024년부터 2030년까지의 분석 기간 동안 CAGR 4.9%로 성장하여 2030년까지 6억 5,240만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석 대상이 된 부문 중 하나인 항체/항원 기반 키트는 4.4%의 CAGR을 기록하며 분석 기간 종료시까지 3억 3,290만 달러에 달할 것으로 예측됩니다. 핵산 증폭 기반 키트 부문의 성장률은 분석 기간 동안 5.8%의 CAGR로 추정됩니다.

미국 시장은 1억 2,900만 달러로 추정되며, 중국은 7.3%의 CAGR로 성장할 것으로 예측됩니다

미국의 헤르페스 마커 검사 시장은 2024년에 1억 2,900만 달러로 추정됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024년부터 2030년까지의 분석 기간 동안 CAGR 7.3%로 증가하여 2030년까지 1억 4,200만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 CAGR 2.6%, 4.3%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 2.7%의 CAGR로 성장할 것으로 예측됩니다.

세계의 헤르페스 마커 검사 시장 - 주요 동향과 촉진요인 요약

헤르페스 마커 검사가 바이러스 감염을 효과적으로 관리할 수 있는 열쇠가 될 수 있을까?

헤르페스 마커 검사는 단순포진바이러스(HSV) 감염을 진단하고 관리하는 데 중요한 역할을 하는데, 왜 이 검사가 그렇게 중요한 것일까? 헤르페스 마커 검사는 체내 항체 또는 바이러스 DNA의 존재를 감지하는 데 사용되며, 임상의가 개인이 HSV-1 또는 HSV-2(이 바이러스의 가장 흔한 두 가지 균주)에 감염되었는지 여부를 확인하는 데 도움이 됩니다. HSV-1은 일반적으로 구강 헤르페스(구순 포진)와 관련이 있고, HSV-2는 생식기 포진과 관련이 있지만, 두 유형 모두 어느 부위에나 감염될 수 있습니다. 헤르페스 감염은 널리 퍼져 있으며, 전 세계적으로 수백만 명의 사람들이 바이러스에 감염되어 있으며, 대부분 무증상인 경우가 많기 때문에 자신이 보균자라는 사실을 인식하지 못하는 경우가 많습니다.

헤르페스 마커 검사는 특히 무증상자나 경증인 경우 자신도 모르게 타인에게 바이러스를 감염시킬 수 있기 때문에 바이러스 진단에 매우 중요합니다. 헤르페스 검사에서는 감염에 대해 면역체계가 생성하는 특정 항체(IgG 또는 IgM)를 확인하거나 중합효소 연쇄 반응(PCR) 검사를 통해 바이러스 DNA를 검출합니다. 이러한 검사는 바이러스에 노출된 적이 있는지 여부를 확인하는 데 도움이 되며, 많은 경우 감염이 최근에 발생했는지 또는 장기간에 걸쳐 발생했는지를 알 수 있습니다. 헤르페스 마커 검사를 통한 정확한 진단은 발병 관리, 감염 위험 감소, 증상 관리 및 합병증 예방을 위한 치료 옵션에 대한 지침이 될 수 있습니다.

헤르페스 마커 검사는 어떻게 기술이 발전했을까?

기술의 발전으로 헤르페스 마커 검사는 정확성, 속도, 접근성이 크게 향상되었습니다. 이 분야에서 가장 중요한 혁신 중 하나는 바이러스 DNA를 직접 검출할 수 있는 중합효소 연쇄 반응(PCR) 검사의 개발입니다. PCR 검사는 민감도가 높아 혈액, 타액, 병변부위 면봉 등 다양한 검체에서 미량의 바이러스도 검출할 수 있습니다. 이 방법은 신속하고 정확한 결과를 제공하며, 종종 몇 시간 내에 결과가 나오기 때문에 활동성 헤르페스 감염을 감지하는 가장 신뢰할 수 있는 진단 도구 중 하나입니다. 특히 급성 발병 등 신속한 확진 진단이 필요한 경우, PCR 검사는 HSV 감염 진단의 표준이 되고 있습니다.

HSV에 대한 항체의 존재를 확인하는 혈청학적 검사도 개선되었습니다. 기존의 혈액 검사로는 HSV-1과 HSV-2의 감염을 구분하기 어려운 경우가 있습니다. 그러나 현대의 혈청학적 검사로 유형별 항체 검출이 가능해져 임상의가 두 종류의 바이러스를 구별할 수 있게 되었습니다. 이 구분은 매우 중요합니다. HSV-1과 HSV-2는 감염 경로와 재발률이 달라 환자의 감염 관리 방식에 영향을 미칠 수 있기 때문입니다. 형 특이적 IgG 항체 검사는 과거 감염 여부를 나타내며, IgM 검사는 최근 감염 또는 최초 감염을 확인하는 데 도움이 됩니다.

또한, 헤르페스에 대한 POC(Point of Care) 검사의 이용 가능성도 높아지고 있습니다. 이러한 신속 검사는 즉각적인 결과를 제공하기 때문에 신속한 진단이 중요한 응급실이나 성병 클리닉에서 유용하게 사용할 수 있습니다. 또한, 새로운 기술로는 HSV와 동시에 여러 성병(STI)을 동시에 검출할 수 있는 멀티플렉스 검사도 연구되고 있습니다. 이를 통해 효율성을 높이고 중복 감염을 진단하는 데 필요한 검사 횟수를 줄일 수 있습니다. 이러한 헤르페스 마커 검사의 발전은 진단 정확도를 높일 뿐만 아니라 검사 과정을 가속화하여 조기 개입과 헤르페스 감염을 더 잘 관리할 수 있게 해줍니다.

헤르페스 마커 검사가 공중 보건 및 개인 관리에서 중요한 이유는 무엇인가?

헤르페스 마커 검사는 특히 증상이 경미하거나 무증상인 경우 개인과 의료 서비스 제공자가 헤르페스 바이러스 감염의 확산을 감지하고 통제할 수 있기 때문에 공중 보건과 개인 관리에 매우 중요합니다. 헤르페스 감염자 중 상당수는 자신의 감염 사실을 모르고 있습니다. 왜냐하면 헤르페스 바이러스는 장기간 체내에서 휴면상태를 유지하다가 스트레스나 질병, 면역력 저하 등의 요인에 의해 발병할 때만 증상이 나타나기 때문입니다. 적절한 검사를 받지 않으면 감염자는 자신도 모르게 다른 사람에게 바이러스를 감염시켜 감염 확산에 일조할 수 있습니다. 헤르페스 마커 검사를 통해 보균자를 확인하고 항바이러스제 사용, 안전한 성행위 등 예방 조치를 취함으로써 감염 위험을 줄일 수 있습니다.

특히 성기나 구강의 통증, 가려움증, 불쾌감 등 원인을 알 수 없는 증상이 있는 경우, 헤르페스 마커 검사는 명확한 진단과 안도감을 줄 수 있습니다. 확진 진단을 통해 의료진은 개별적인 관리 계획을 수립할 수 있습니다. 이는 아시클로버, 바라시시비르, 팜시시비르 등의 항바이러스제로 발병 빈도 및 중증도를 감소시키는 것을 포함할 수 있습니다. HSV 감염 여부를 알면, 특히 무증상 바이러스 배출 기간(감염력이 지속되는 시기)에 성 파트너에게 감염되지 않도록 예방 조치를 취할 수 있습니다.

임산부의 경우, 헤르페스 마커 검사가 특히 중요합니다. HSV 감염, 특히 임신 중 감염된 경우 태아에게 위험을 초래할 수 있습니다. 신생아 헤르페스라는 심각한 질환을 유발할 수 있으며, 신속한 치료가 이루어지지 않으면 영구적인 장애나 사망으로 이어질 수 있습니다. 헤르페스 감염을 조기에 발견하면 의사는 예방 조치를 취할 수 있습니다. 예를 들어, 임신 후기에 항바이러스제를 처방하거나 분만 시 활동성 병변이 있는 경우 제왕절개술을 권장함으로써 신생아에게 바이러스가 전파될 위험을 줄일 수 있습니다.

더 넓은 관점에서 볼 때, 헤르페스 마커 검사는 HSV 감염이 공중 보건에 미치는 영향을 관리하는 데 매우 중요합니다. 이 바이러스는 세계에서 가장 널리 퍼진 성병 중 하나이며, 검사 보급을 통해 보균자를 찾아내어 치료함으로써 감염률 감소를 기대할 수 있습니다. 헤르페스 감염을 조기에 발견하고 효과적으로 관리하면 검사 및 치료를 받는 것을 방해하는 요인인 바이러스에 대한 편견을 줄이는 데에도 기여합니다. 검사를 일상화하고 진단에 쉽게 접근할 수 있도록함으로써 공중보건 시스템은 HSV의 확산을 보다 효과적으로 관리하고, 취약 계층을 보호하며, 바이러스에 감염된 사람들의 삶의 질을 향상시킬 수 있습니다.

헤르페스 마커 검사 시장의 성장을 이끄는 요인은 무엇인가?

헤르페스 마커 검사 시장의 성장은 성병(STI)에 대한 인식 증가, 검사 기술의 발전, 전 세계 헤르페스 바이러스 감염 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 STI와 정기적인 검진의 중요성에 대한 인식의 확대입니다. 공중보건 캠페인과 교육 프로그램은 특히 HSV 감염이 무증상 감염이라는 인식이 높아짐에 따라 더 많은 사람들이 헤르페스 및 기타 STI 검사를 받도록 독려하고 있습니다. 이러한 공중보건 인식의 변화로 인해 진료소, 병원 및 가정용 검사 키트에서 헤르페스 마커 검사에 대한 수요가 증가하고 있습니다.

진단 검사 기술의 발전도 헤르페스 마커 검사 시장의 성장에 기여하고 있습니다. PCR 검사, 멀티플렉스 검사 등 보다 정확하고 신속하며 비용 효율적인 검사법의 개발로 의료진과 환자 모두에게 헤르페스 진단이 더욱 친숙해졌습니다. 이러한 기술은 검사 결과를 신속하게 제공할 수 있으며, 특히 급성 발병 관리 및 감염 예방에 매우 중요합니다. 빠른 결과를 제공하는 POC(Point of Care) 검사 도입도 시장 확대를 촉진하는 요인 중 하나입니다. 특히 의료 인프라가 부족한 지역이나 치료 결정을 위해 즉각적인 결과가 필요한 지역에서 더욱 두드러집니다.

헤르페스 감염 유병률의 증가도 시장 성장을 이끄는 중요한 요인입니다. 세계보건기구(WHO)의 추산에 따르면, 50세 미만 37억 명 이상이 HSV-1에, 15-49세 4억 9,000만 명 이상이 HSV-2에 감염된 것으로 추정됩니다. 헤르페스 감염은 여전히 널리 퍼져 있고 치료가 어렵기 때문에 헤르페스 감염 관리 및 경과 관찰에 효과적인 진단 도구에 대한 수요는 계속 확대되고 있습니다. 미진단 또는 미치료 헤르페스와 관련된 건강 위험(임신 중 합병증, HIV 감염 위험 증가 등)에 대한 인식이 높아지면서 검사를 받으려는 사람들이 증가하고 있습니다.

자가 검사 옵션의 증가도 시장 확대에 기여하는 추세입니다. 원격의료와 디지털 헬스 플랫폼의 보급과 함께 가정용 헤르페스 검사 키트의 인기가 높아지면서 개인이 편리하고 눈에 띄지 않게 간편하게 HSV 감염 여부를 파악할 수 있는 수단을 제공하고 있습니다. 이 키트를 사용하면 집에서 검체를 채취하여 검사 기관에 보낼 수 있으며, 결과는 안전한 온라인 플랫폼을 통해 비밀리에 통보됩니다. 이러한 서비스가 제공하는 편리함과 프라이버시 보호로 인해, 특히 젊은 층과 테크놀러지에 익숙한 계층을 중심으로 자신의 성건강을 관리하고 검사하는 사람들이 증가하고 있습니다.

마지막으로, 성병의 확산을 억제하기 위한 헬스케어 정책 및 정부 프로그램의 증가가 헤르페스 마커 검사에 대한 수요를 견인하고 있습니다. 각국 정부와 국제보건기구는 헤르페스를 비롯한 감염성 질환에 대한 진단 검사 접근성 확대를 포함한 성병 예방 및 관리 프로그램에 대한 투자를 진행하고 있습니다. 이러한 노력은 일반인들의 인식 개선 및 기술 발전과 함께 향후 몇 년 동안 헤르페스 마커 검사 시장의 꾸준한 성장을 촉진하고, 더 많은 사람들이 정확한 진단과 효과적인 치료를 받을 수 있는 환경을 조성할 것으로 예상됩니다.

부문:

검사 유형(항체/항원 베이스 키트, 핵산 증폭 베이스 키트, 바이러스 배양 검사), 최종 용도(진단센터, 병원, 진료소, 학계 및 연구기관)

조사 대상 기업 예시

  • Abbott Laboratories
  • Abcam PLC
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Meridian Bioscience, Inc.
  • Norgen Biotek Corporation
  • Qiagen NV
  • Quidel Corporation
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc.

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 조회하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등이 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하는 가운데, 이번 보고서에서는 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.12.18

Global Herpes Marker Testing Market to Reach US$652.4 Million by 2030

The global market for Herpes Marker Testing estimated at US$490.0 Million in the year 2024, is expected to reach US$652.4 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the end of the analysis period. Growth in the Nucleic Acid Amplification-based Kits segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$129.0 Million While China is Forecast to Grow at 7.3% CAGR

The Herpes Marker Testing market in the U.S. is estimated at US$129.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$142.0 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Herpes Marker Testing Market - Key Trends and Drivers Summarized

Is Herpes Marker Testing the Key to Effective Management of Viral Infections?

Herpes marker testing plays a critical role in diagnosing and managing herpes simplex virus (HSV) infections, but why is this testing so essential? Herpes marker tests are used to detect the presence of antibodies or viral DNA in the body, helping clinicians identify whether an individual has been infected with HSV-1 or HSV-2, the two most common strains of the virus. HSV-1 is typically associated with oral herpes (cold sores), while HSV-2 is more commonly linked to genital herpes, although both types can infect either region. Herpes infections are widespread, with millions of people worldwide living with either type of the virus, many of whom are unaware they are carriers due to the often asymptomatic nature of the infection.

Herpes marker testing is critical for diagnosing the virus, particularly in asymptomatic individuals or those with mild symptoms, as they can unknowingly transmit the virus to others. Testing for herpes involves identifying specific antibodies (IgG or IgM) that the immune system produces in response to the infection or detecting viral DNA through polymerase chain reaction (PCR) tests. These tests help confirm whether someone has been exposed to the virus and, in many cases, can indicate whether the infection is recent or long-standing. Accurate diagnosis through herpes marker testing is essential for managing outbreaks, reducing the risk of transmission, and guiding treatment options to help individuals manage symptoms and prevent complications.

How Has Technology Advanced Herpes Marker Testing?

Technological advancements have significantly improved herpes marker testing, making it more accurate, faster, and accessible. One of the most significant innovations in this field is the development of polymerase chain reaction (PCR) testing, which allows for the direct detection of viral DNA. PCR testing is highly sensitive and can detect even small amounts of the virus in various sample types, such as blood, saliva, or lesion swabs. This method offers rapid and precise results, often within a few hours, making it one of the most reliable diagnostic tools for detecting active herpes infections. PCR tests have become the gold standard for diagnosing HSV infections, especially in cases where a definitive diagnosis is needed quickly, such as during an acute outbreak.

Serological testing, which identifies the presence of antibodies against HSV, has also improved. Traditional blood tests could sometimes struggle to differentiate between HSV-1 and HSV-2 infections. However, modern serological tests now offer type-specific antibody detection, allowing clinicians to distinguish between the two types of the virus. This distinction is crucial because HSV-1 and HSV-2 have different transmission patterns and recurrence rates, which can influence how a patient manages their infection. Type-specific IgG antibody tests can indicate whether someone has had a past infection, while IgM tests help identify recent or primary infections.

Additionally, point-of-care (POC) testing for herpes is becoming increasingly available. These rapid tests offer on-the-spot results, making them useful in urgent care or sexual health clinics where quick diagnosis is critical. Newer technologies are also exploring multiplex testing, which allows for the simultaneous detection of multiple sexually transmitted infections (STIs) alongside HSV, improving efficiency and reducing the number of tests needed to diagnose co-infections. These advancements in herpes marker testing not only improve diagnostic accuracy but also speed up the process, enabling earlier intervention and better management of herpes infections.

Why Is Herpes Marker Testing Critical for Public Health and Personal Management?

Herpes marker testing is vital for public health and personal management because it enables individuals and healthcare providers to detect and control the spread of herpes simplex virus infections, particularly when symptoms are mild or absent. Many people with herpes are unaware of their infection because it can remain dormant in the body for long periods, only causing outbreaks when triggered by factors like stress, illness, or a weakened immune system. Without proper testing, these individuals may unknowingly transmit the virus to others, contributing to its spread. Testing for herpes markers helps identify carriers and allows them to take precautions, such as using antiviral medications or practicing safer sexual behaviors, to reduce the risk of transmission.

For individuals, herpes marker testing provides clarity and peace of mind, particularly if they are experiencing unexplained symptoms like genital or oral sores, itching, or discomfort. A confirmed diagnosis allows healthcare providers to develop a tailored management plan, which may include antiviral medications like acyclovir, valacyclovir, or famciclovir to reduce the frequency and severity of outbreaks. Knowing their HSV status also empowers individuals to take preventive steps to avoid passing the virus to sexual partners, especially during asymptomatic shedding when the virus can still be transmitted.

In pregnant women, herpes marker testing is particularly critical. HSV infections, especially when acquired during pregnancy, can pose risks to the baby, leading to neonatal herpes, a serious condition that can cause permanent disability or death if not treated promptly. Identifying herpes infections early allows doctors to take preventive measures, such as prescribing antiviral medications in the late stages of pregnancy or recommending a cesarean delivery if there are active lesions during labor, to reduce the risk of transmitting the virus to the newborn.

On a larger scale, herpes marker testing is crucial for managing the overall public health impact of HSV infections. The virus is one of the most prevalent sexually transmitted infections globally, and widespread testing can help reduce its transmission rate by identifying and treating carriers. Early detection and effective management of herpes infections also help reduce the stigma associated with the virus, which can prevent individuals from seeking testing or treatment. By normalizing testing and offering easy access to diagnostics, public health systems can more effectively manage the spread of HSV, protect vulnerable populations, and improve the quality of life for those living with the virus.

What Factors Are Driving the Growth of the Herpes Marker Testing Market?

The growth of the herpes marker testing market is driven by several key factors, including rising awareness of sexually transmitted infections (STIs), advancements in testing technologies, and the increasing prevalence of herpes simplex virus infections globally. One of the primary drivers is the growing awareness of STIs and the importance of regular screening. Public health campaigns and educational programs are encouraging more people to get tested for herpes and other STIs, particularly as awareness increases about the asymptomatic nature of HSV infections. This shift in public health awareness is leading to higher demand for herpes marker testing in clinics, hospitals, and at-home testing kits.

Technological advancements in diagnostic testing are also contributing to the growth of the herpes marker testing market. The development of more accurate, faster, and cost-effective tests, such as PCR and multiplex testing, is making herpes diagnostics more accessible to healthcare providers and patients. These technologies allow for quicker turnaround times, which is especially important in managing acute outbreaks and preventing transmission. The introduction of point-of-care (POC) tests that deliver rapid results is another factor fueling market expansion, particularly in regions where healthcare infrastructure may be limited or where immediate results are necessary for treatment decisions.

The rising prevalence of herpes infections is another significant factor driving market growth. The World Health Organization (WHO) estimates that more than 3.7 billion people under the age of 50 have HSV-1, and over 490 million people aged 15-49 have HSV-2. As these infections remain widespread and incurable, the demand for effective diagnostic tools to manage and monitor herpes infections continues to grow. The increasing recognition of the health risks associated with undiagnosed or untreated herpes, such as complications during pregnancy and heightened risk of HIV transmission, is prompting more individuals to seek testing.

The growth of at-home testing options is another trend contributing to market expansion. With the rise of telemedicine and digital health platforms, at-home herpes testing kits are becoming more popular, providing a convenient, discreet, and accessible way for individuals to learn their HSV status. These kits allow users to collect a sample at home and send it to a laboratory for analysis, with results delivered confidentially via secure online platforms. The convenience and privacy offered by these services are encouraging more people, particularly younger and tech-savvy populations, to take charge of their sexual health and get tested.

Lastly, increasing healthcare initiatives and government programs aimed at reducing the prevalence of sexually transmitted infections are driving demand for herpes marker testing. Governments and global health organizations are investing in STI prevention and control programs, which include expanding access to diagnostic testing for herpes and other infections. These initiatives, combined with greater public awareness and technological advancements, are expected to drive steady growth in the herpes marker testing market in the coming years, ensuring that more individuals can access accurate diagnostics and effective care.

SCOPE OF STUDY:

The report analyzes the Herpes Marker Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Antibody / Antigen-Based Kits, Nucleic Acid Amplification-Based Kits, Viral Culture Test); End-Use (Diagnostic Centers, Hospitals, Clinics, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Abcam PLC
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Meridian Bioscience, Inc.
  • Norgen Biotek Corporation
  • Qiagen NV
  • Quidel Corporation
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Herpes Marker Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Herpes Infections Propels Demand for Herpes Marker Testing
    • Expansion of Diagnostic Testing in Sexual Health Clinics Fuels Market Growth
    • Role of Herpes Marker Testing in Reducing Transmission Rates and Enhancing Public Health Efforts
    • Expansion of Home-based and Self-testing Solutions Strengthens Business Case for Herpes Diagnostics
    • Growth in Digital Health Platforms for Telemedicine Consultations Expands Addressable Market
    • Challenges in Managing Social Stigma and Awareness of Herpes Infections Pose Barriers to Adoption
    • Expansion of Testing in Prenatal Care and High-risk Populations Drives Market Demand
    • Growth in Use of Multiplex Testing Panels for STDs Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Antibody / Antigen-Based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Antibody / Antigen-Based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Antibody / Antigen-Based Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nucleic Acid Amplification-based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nucleic Acid Amplification-based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nucleic Acid Amplification-based Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Viral Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Viral Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Viral Culture Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Herpes Marker Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Herpes Marker Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • JAPAN
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • CHINA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • EUROPE
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Herpes Marker Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • GERMANY
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Herpes Marker Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • INDIA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Herpes Marker Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Herpes Marker Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030
  • AFRICA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제